JP2020522490A5 - - Google Patents

Download PDF

Info

Publication number
JP2020522490A5
JP2020522490A5 JP2019566121A JP2019566121A JP2020522490A5 JP 2020522490 A5 JP2020522490 A5 JP 2020522490A5 JP 2019566121 A JP2019566121 A JP 2019566121A JP 2019566121 A JP2019566121 A JP 2019566121A JP 2020522490 A5 JP2020522490 A5 JP 2020522490A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
dihydroisobenzofuran
pyrazole
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019566121A
Other languages
English (en)
Japanese (ja)
Other versions
JP7084946B2 (ja
JP2020522490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/035270 external-priority patent/WO2018222795A1/en
Publication of JP2020522490A publication Critical patent/JP2020522490A/ja
Publication of JP2020522490A5 publication Critical patent/JP2020522490A5/ja
Priority to JP2022090971A priority Critical patent/JP7406592B2/ja
Application granted granted Critical
Publication of JP7084946B2 publication Critical patent/JP7084946B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019566121A 2017-06-01 2018-05-31 置換窒素含有化合物 Active JP7084946B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022090971A JP7406592B2 (ja) 2017-06-01 2022-06-03 置換窒素含有化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN201711019293 2017-06-01
IN201711019293 2017-06-01
IN201811004486 2018-02-06
IN201811004486 2018-02-06
PCT/US2018/035270 WO2018222795A1 (en) 2017-06-01 2018-05-31 Substituted nitrogen containing compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022090971A Division JP7406592B2 (ja) 2017-06-01 2022-06-03 置換窒素含有化合物

Publications (3)

Publication Number Publication Date
JP2020522490A JP2020522490A (ja) 2020-07-30
JP2020522490A5 true JP2020522490A5 (enExample) 2021-06-10
JP7084946B2 JP7084946B2 (ja) 2022-06-15

Family

ID=62685190

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019566121A Active JP7084946B2 (ja) 2017-06-01 2018-05-31 置換窒素含有化合物
JP2022090971A Active JP7406592B2 (ja) 2017-06-01 2022-06-03 置換窒素含有化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022090971A Active JP7406592B2 (ja) 2017-06-01 2022-06-03 置換窒素含有化合物

Country Status (27)

Country Link
US (6) US10501449B2 (enExample)
EP (2) EP3630752B1 (enExample)
JP (2) JP7084946B2 (enExample)
KR (1) KR102655318B1 (enExample)
CN (1) CN110678463B (enExample)
AU (1) AU2018275552B2 (enExample)
CA (1) CA3065309A1 (enExample)
CL (1) CL2019003486A1 (enExample)
CO (1) CO2019013589A2 (enExample)
CY (1) CY1124479T1 (enExample)
DK (1) DK3630752T3 (enExample)
ES (2) ES2885243T3 (enExample)
HR (1) HRP20211262T1 (enExample)
HU (1) HUE056142T2 (enExample)
IL (1) IL271036B2 (enExample)
LT (1) LT3630752T (enExample)
MX (1) MX389581B (enExample)
MY (1) MY201325A (enExample)
PE (1) PE20200386A1 (enExample)
PL (1) PL3630752T3 (enExample)
PT (1) PT3630752T (enExample)
RS (1) RS62277B1 (enExample)
SI (1) SI3630752T1 (enExample)
SM (1) SMT202100512T1 (enExample)
TW (1) TWI791527B (enExample)
WO (1) WO2018222795A1 (enExample)
ZA (1) ZA201908488B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201903871TA (en) 2016-11-03 2019-05-30 Bristol Myers Squibb Co Substituted bicycle heterocyclic derivatives useful as romk channel inhibitors
CN110678463B (zh) * 2017-06-01 2023-06-06 百时美施贵宝公司 经取代的含氮化合物
CN114980887A (zh) 2019-12-20 2022-08-30 特纳亚治疗股份有限公司 氟代烷基-噁二唑及其用途
EP4146219A4 (en) * 2020-05-06 2024-05-22 Biohaven Therapeutics Ltd. PROCESS FOR PREPARING VERDIPERSTAT
WO2022235842A1 (en) 2021-05-04 2022-11-10 Tenaya Therapeutics, Inc. 2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef
CN114957222B (zh) * 2022-05-31 2023-08-15 内蒙古民族大学 化合物及其制备方法和用途
CN114907323B (zh) * 2022-05-31 2023-08-15 内蒙古民族大学 喹喔啉酮类化合物及其制备方法和应用
WO2025264844A1 (en) * 2024-06-20 2025-12-26 Lieber Institute, Inc. Heterocyclic gpr52 modulators and methods of use thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1106605A4 (en) 1999-06-24 2005-12-07 Toray Industries ANTAGONISTS OF THE ADRENERGIC RECEPTOR-ALPHA1B
US6921763B2 (en) 1999-09-17 2005-07-26 Abbott Laboratories Pyrazolopyrimidines as therapeutic agents
CN100376592C (zh) 2001-06-20 2008-03-26 橘生药品工业株式会社 含氮的杂环衍生物、含有该衍生物的药物组合物、其药物应用以及用于该衍生物制备的中间体
WO2003086279A2 (en) 2002-04-08 2003-10-23 Merck & Co., Inc. Inhibitors of akt activity
WO2003086394A1 (en) 2002-04-08 2003-10-23 Merck & Co., Inc. Inhibitors of akt activity
AU2005263719A1 (en) 2004-07-16 2006-01-26 Janssen Pharmaceutica N.V. Dimeric piperidine derivatives
CA2588517A1 (en) 2004-12-01 2006-06-08 Devgen N.V. 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
SE0403171D0 (sv) 2004-12-23 2004-12-23 Astrazeneca Ab New compounds
BRPI0908565A2 (pt) 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase
US8673920B2 (en) 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
JP5654572B2 (ja) 2009-05-15 2015-01-14 ノバルティス アーゲー アルドステロンシンターゼ阻害剤としてのベンズオキサゾロン誘導体
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
GB0913342D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab Compounds - 801
WO2011103536A1 (en) 2010-02-19 2011-08-25 Arizona Board Of Regents Multifunctional radical quenchers and their use
AU2011302216A1 (en) 2010-09-14 2013-04-04 Exelixis, Inc. Phtalazine derivatives as JAK1 inhibitors
WO2012058116A1 (en) 2010-10-27 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9056859B2 (en) 2010-10-29 2015-06-16 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
KR20140052034A (ko) * 2011-08-19 2014-05-02 머크 샤프 앤드 돔 코포레이션 신장 외수질 칼륨 채널의 억제제
WO2013039802A1 (en) * 2011-09-16 2013-03-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US8999991B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062892A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013066714A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773351B1 (en) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013066717A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2790511B1 (en) 2011-12-16 2016-09-14 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014015495A1 (en) 2012-07-26 2014-01-30 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
WO2014085210A1 (en) 2012-11-29 2014-06-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9573961B2 (en) * 2012-12-19 2017-02-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
US9604998B2 (en) 2013-02-18 2017-03-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2968288B1 (en) 2013-03-15 2018-07-04 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2015017305A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp Inhibitors of the renal outer medullary potassium channel
HUE041652T2 (hu) 2013-10-11 2019-05-28 Hoffmann La Roche TRPA1-modulátorokként hasznos szubsztituált heterociklusos szulfonamid-vegyületek
US9951052B2 (en) * 2013-10-31 2018-04-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP3083573B1 (en) 2013-12-18 2024-08-07 Merck Sharp & Dohme LLC Inhibitors of the renal outer medullary potassium channel
WO2015090579A1 (en) 2013-12-18 2015-06-25 Grünenthal GmbH Pyrazolyl-based carboxamides iv
WO2015096035A1 (en) 2013-12-24 2015-07-02 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel
WO2015103756A1 (en) 2014-01-09 2015-07-16 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016008064A1 (en) 2014-07-14 2016-01-21 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel
MX2017000634A (es) 2014-07-14 2017-05-01 Merck Sharp & Dohme Inhibidores del canal de potasio medularmente externo renal.
WO2016060941A1 (en) 2014-10-14 2016-04-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016065582A1 (en) 2014-10-30 2016-05-06 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016065603A1 (en) 2014-10-31 2016-05-06 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US20170275292A1 (en) 2014-10-31 2017-09-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016065602A1 (en) 2014-10-31 2016-05-06 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel
WO2016091042A1 (zh) 2014-12-08 2016-06-16 江苏恒瑞医药股份有限公司 吡啶甲酰胺类衍生物、其制备方法及其在医药上的应用
CN105693706B (zh) 2014-12-10 2019-11-22 江苏恒瑞医药股份有限公司 异苯并呋喃酮类衍生物、其制备方法及其在医药上的应用
US10513518B2 (en) 2015-01-29 2019-12-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2016127358A1 (en) 2015-02-12 2016-08-18 Merck Sharp & Dohme Corp. Inhibitors of renal outer medullary potassium channel
WO2017001991A1 (en) 2015-06-29 2017-01-05 Crystalmorphix Technologies Pvt. Ltd Cocrystals of trigonelline
EA037300B1 (ru) 2016-04-20 2021-03-05 Бристол-Маерс Сквибб Компани Замещенные бициклические гетероциклические соединения
SG11201903871TA (en) 2016-11-03 2019-05-30 Bristol Myers Squibb Co Substituted bicycle heterocyclic derivatives useful as romk channel inhibitors
CN110678463B (zh) 2017-06-01 2023-06-06 百时美施贵宝公司 经取代的含氮化合物

Similar Documents

Publication Publication Date Title
HRP20211262T1 (hr) Supstituirani spojevi koji sadrže dušik
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
RU2396269C2 (ru) Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpt1)
JP2011503166A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2016519096A5 (enExample)
JP2021502356A5 (enExample)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
US20180334450A1 (en) Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
ME02437B (me) Disupstituirani oktahidropirolo[3,4-c]piroli kao modulatori oreksin receptora
RU2010137300A (ru) Модуляторы бета-амилоида
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
RU2014152625A (ru) Конденсированные с гетероарилкетонами азадекалины - модуляторы глюкокортикоидных рецепторов
HRP20120281T1 (hr) Derivati azabiciklo[3.1.0]heksana, korisni kao modulatori dopaminskih receptora d3
CN115697991A (zh) 哌嗪环状脲
IL310330A (en) Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
RU2019123319A (ru) Пиразолопиримидины и способы их применения
JP2020516672A5 (enExample)
US20240383875A1 (en) Benzimidazole Pyridine Derivatives
HRP20211784T1 (hr) Kombinacijski tretmani koji se sastoje od primjene 1h-pirazolo[4,3-b]piridina
RU2020119080A (ru) Виды комбинированного лечения, предусматривающего введение 1h-пиразолo[4,3-b]пиридинов
KR101898364B1 (ko) 인돌린-2-온 및 1,3-다이하이드로-피롤로[3,2-c]피리딘-2-온 유도체
KR20190070985A (ko) RORc 조절제로서의 피리다진 유도체
RU2024120925A (ru) Новые пиридиновые производные бензимидазола